Results 71 to 80 of about 111,900 (264)

Cancer of the vulva: 2025 update

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye, Mauricio A. Cuello, Sushil Beriwal, Linda J. Rogers   +3 more
wiley   +1 more source

Uterine lesions with sex cord-like architectures: a systematic review

Diagnostic Pathology, 2019
Background Sex cord-like elements are rarely observed in uterine lesions, but these morphological patterns could appear in a variety of uterine tumors and non-tumorous lesions.
Meng Jia, Ping-Li Sun, Hongwen Gao
doaj   +1 more source

Cancer and fertility management: FIGO best practice advice

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Cancer diagnoses in patients of reproductive age require balancing urgent oncological treatment with the need to preserve fertility. This FIGO Best Practice Advice outlines key considerations for fertility management in this population given the rising cancer incidence among young women and the reproductive risks posed by cancer treatments ...
Nikhil Purandare, Francisco Ruiloba, Long Nguyen‐Hoang, Sarikapan Wilailak, Nozomu Yanaihara, Jacqueline P. W. Chung, Jaideep Malhotra, Edgar Mocanu, Frédéric Amant, Orla McNally, Inge Peters, Katie Flynn, Aya El Helali, Cynthia Maxwell, Sumaiya Adam, Lina Bergman, Surabhi Nanda, Valerie Tiempo Guinto, Fionnuala M. McAuliffe, Catherine Nelson‐Piercy, Melanie Nana, Graeme Smith, Jonathan Berek, Sharleen O'Reilly, Pat O'Brien, Bo Jacobsson, Liona C. Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health and the FIGO Division of Maternal and Newborn Health and in collaboration with the FIGO Committee on Women's Cancer and the FIGO Committee on Reproductive Medicine, Endocrinology and Infertility   +28 more
wiley   +1 more source

Supplementary Figure 5 from Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors [PDF]

, 2023
Ann H. Klopp, Yan Zhang, Travis Solley, Felipe Amaya‐Manzanares, Frank C. Marini, Michael Andreeff, Bisrat G. Debeb, Wendy A. Woodward, Rosemarie Schmandt, Russell R. Broaddus, Karen H. Lu, Mikhail G. Kolonin   +11 more
openalex   +2 more sources

High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report of a 69-YearOld Iranian patient

Case Reports in Clinical Practice
Reporting clinical cases of high-grade endometrial stromal sarcoma tumors is essential for a better understanding of their natural course and for the development of appropriate diagnostic and treatment strategies.
Faraz Mahdizadeh, Mir Mehdi Chinifroush-Asl, Farzad Heidary, Hamid Hataminia   +3 more
doaj   +1 more source

Low-grade endometrial stromal sarcoma in a postmenopausal woman with third-degree uterovaginal prolapse: A rare case with review of the literature

Journal of Mid-Life Health, 2018
Endometrial stromal sarcomas (ESSs) are rare malignant tumors of the uterus that arise from the endometrial stroma, the annual incidence of ESS being 1–2/million women.
Meenakshi Gothwal, Garima Yadav, Meenakshi Rao, Pratibha Singh, Aasma Nalwa   +4 more
doaj   +1 more source

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

A Case Report of a Severely Aggressive Uterine Sarcoma at an Unusual Age [PDF]

Journal of Kerman University of Medical Sciences, 2016
Uterine sarcomas are very unique tumors with mesodermial origin and accounting for 2-6% of uterine cancers. In general, uterine sarcomas are the most malignant tumors of the uterus.
zahra honarvar, Mohades Peydayesh
doaj  

Intravenous metastasis of unexpected uterine sarcoma in the context of uterine fibroids: case report and literature review

Frontiers in Oncology
ObjectiveEndometrial stromal tumors are rare and complex mesenchymal tumors that often present with clinical symptoms similar to uterine leiomyomas. Due to their atypical nature, they are prone to be misdiagnosed or overlooked by healthcare professionals.
Wenying Huang, Tianwei Zhang, Tianwei Zhang, Hui Wang, Zhengchun Liu, Peiling Zhai, Xinbo Wang, Shuai Wang   +7 more
doaj   +1 more source

Uterine sarcomas: clinical presentation and MRI features

Diagnostic and Interventional Radiology, 2015
Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for approximately 8% of uterine malignancies. They comprise leiomyosarcoma, endometrial stromal sarcoma, undifferentiated endometrial sarcoma, and adenosarcoma ...
Pedro Santos, Teresa Margarida Cunha
doaj   +1 more source